# Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial

> **NCT06093932** · PHASE4 · RECRUITING · sponsor: **Xiyuan Hospital of China Academy of Chinese Medical Sciences** · enrollment: 100 (estimated)

## Conditions studied

- Hypertension,Essential

## Interventions

- **DRUG:** Songling Xuemaikang Capsules
- **BEHAVIORAL:** Lifestyle intervention
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06093932
- **Lead sponsor:** Xiyuan Hospital of China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-07
- **Primary completion:** 2024-12
- **Final completion:** 2027-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-08-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06093932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06093932, "Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06093932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*